Insulin Resistance and Cognitive Dysfunction in Obese Adolescents: Pilot Study
1 other identifier
interventional
56
1 country
1
Brief Summary
Obese Adolescents will be evaluated for insulin resistance and cognitive dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Dec 2012
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2012
CompletedFirst Posted
Study publicly available on registry
November 29, 2012
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedFebruary 15, 2019
February 1, 2019
3.2 years
November 5, 2012
February 13, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Formal exercise intervention and cognitive dysfunction in obeses adolescents
To measure the feasibility of recruiting extremely obese (BMI \> 99%tile corrected for age) children and adolescents into an exercise program and evaluate their physical fitness.
1 year
Secondary Outcomes (2)
Systemic and Cognitive effects of adding exercise program to obese adolescent's lifestyle.
1 year
Systemic and Cognitive effects of adding exercise program to obese adolescent's lifestyle.
1 year
Study Arms (2)
Exercise Program upon enrollment
OTHERSubject will receive exercise intervention immediately upon enrollment to study
Exercise Program 6 months after enrollment
OTHERSubject will be enrolled into study and then receive exercise intervention 6 months after enrollment.
Interventions
Exercise Program for Obese Adolescents
Eligibility Criteria
You may qualify if:
- Male and female subject's ages 14 to 19 years old, extremely obese (BMI ≥ 99th percentile).
- Clearance by pediatric cardiologist, including evaluation of V02Max.
You may not qualify if:
- Male and female less than 14years of age or more than 19 years of age.
- Patients with type 1 or type 2 diabetes
- Patients with serious medical conditions.
- Anyone who is deemed inappropriate by pediatric cardiologist during clearance evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Winthrop University Hospital
Mineola, New York, 11501, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Siham Accacha, MD
Winthrop University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2012
First Posted
November 29, 2012
Study Start
December 1, 2012
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
February 15, 2019
Record last verified: 2019-02